Biofrontera Inc. (NASDAQ:BFRI) Short Interest Up 19.7% in March

Biofrontera Inc. (NASDAQ:BFRI) was the target of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 97,800 shares, an increase of 19.7% from the February 28th total of 81,700 shares. Based on an average daily trading volume, of 384,300 shares, the short-interest ratio is currently 0.3 days. Approximately 1.3% of the company’s shares are short sold.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Rosalind Advisors Inc. increased its stake in Biofrontera by 63.9% in the fourth quarter. Rosalind Advisors Inc. now owns 811,918 shares of the company’s stock valued at $885,000 after purchasing an additional 316,428 shares during the last quarter. Virtu Financial LLC purchased a new stake in Biofrontera in the 4th quarter valued at about $48,000. Finally, AIGH Capital Management LLC increased its stake in shares of Biofrontera by 61.8% during the 4th quarter. AIGH Capital Management LLC now owns 811,097 shares of the company’s stock valued at $884,000 after acquiring an additional 309,663 shares during the last quarter. Hedge funds and other institutional investors own 10.08% of the company’s stock.

Biofrontera Stock Performance

Shares of BFRI opened at $0.79 on Friday. Biofrontera has a 1 year low of $0.65 and a 1 year high of $2.43. The company’s 50 day simple moving average is $1.00 and its 200 day simple moving average is $1.01. The company has a market capitalization of $6.99 million, a price-to-earnings ratio of -0.35 and a beta of 0.30.

About Biofrontera

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.